Investigación / Grupos de investigación

Grupo  27

Farmacia Hospitalaria y Farmacogenómica

Publicaciones (402)

  • Olmedo, M; Kestler, M; Valerio, M; Padilla, B; Rodríguez González C; Chamarro E; Machado, M; Alvarez-Uria, A; Alcala, L; Muñoz P; Bouza, E.

    Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience

    REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35(3): 279-283 Nº de citas: 7 [doi:10.37201/req/120.2021]

  • Escudero-Vilaplana, V; Bernal, E; Casado, G; Collado-Borrell, R; Diez-Fernandez, R; Roman, ABF; Folguera, C; Gonzalez-Cortijo, L; Herrero-Fernandez, M; Marquina, G; Nieto, CM; Rodriguez, MA; Rubio, AR; Sanmartin-Fenollera, P; Castillo, MJV; Comellas, M; Guerra, EM.

    Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer

    Frontiers in Oncology. 2022; 12: Nº de citas: 4 [doi:10.3389/fonc.2022.885910]

  • Villanueva-Bueno, C; Collado-Borrell, R; Revuelta-Herrero, JL; Fernandez-Roman, AB; Casado-Abad, G; Escudero-Vilaplana, V.

    Implementation of a methodology to assess patient reported outcomes in lung cancer patients: The PeOpLe (Patient-reported Outcomes in Lung cancer) study protocol

    FARMACIA HOSPITALARIA. 2022; 46(4): 265-269 Nº de citas: 1 [doi:10.7399/fh.11835]

  • Collado-Borrell, R; Escudero-Vilaplana, V; Narrillos-Moraza, A; Villanueva-Bueno, C; Herranz-Alonso, A; Sanjurjo-Saez, M.

    Patient-reported outcomes and mobile applications. A review of their impact on patients' health outcomes

    FARMACIA HOSPITALARIA. 2022; 46(3): 173-181 Nº de citas: 4 [doi:10.7399/fh.11830]

  • Moreno-Martinez, E; de la Serna-Torroba, J; Escudero-Vilaplana, V; Hernandez-Rivas, JA; Sanchez-Cuervos, M; Sanchez-Hernandez, R.

    Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain

    FARMACIA HOSPITALARIA. 2022; 46(3): 121-132 [doi:10.7399/fh.11829]

  • Martinez-Barrio, J; Lopez, JAM; Galindo, M; Ais, A; Sanchez, NM; Cano, L.

    Importance of family planning in patients with immune-mediated inflammatory diseases: A multidisciplinary approach

    Reumatologia Clinica. 2022; 18(4): 200-206

  • Garcia-Sanchez, S; Somoza-Fernadez, B; de Lorenzo-Pinto, A; Ortega-Navarro, C; Herranz-Alonso, A; Sanjurjo, M.

    Mobile Health Apps Providing Information on Drugs for Adult Emergency Care: Systematic Search on App Stores and Content Analysis

    JMIR mHealth and uHealth. 2022; 10(4): Nº de citas: 7 [doi:10.2196/29985]

  • Diaz-Navarro, M; Hafian, R; Manzano, I; Perez-Granda, MJ; Cercenado, E; Pascual, C; Rodriguez, C; Munoz, P; Guembe, M.

    A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing

    Infectious Diseases and Therapy. 2022; 11(2): 743-755 Nº de citas: 4 [doi:10.1007/s40121-021-00579-4]

  • Hoyo-Munoz, A; Collado-Borrell, R; Escudero-Vilaplana, V; Bastos-Oreiro, M; Herranz-Alonso, A; Sanjurjo-Saez, M.

    Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease

    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2022; 47(4): 548-551 Nº de citas: 3 [doi:10.1111/jcpt.13513]

  • Amor-Garcia, MA; Rodriguez-Gonzalez, CG; Chamorro-de-Vega, E; Herranz-Alonso, A; Sanjurjo-Saez, M.

    Dolutegravir-Based Dual Therapies in HIV Pretreated Patients: A Real-Life Study in Madrid

    ANNALS OF PHARMACOTHERAPY. 2022; 56(4): 401-411 Nº de citas: 7 [doi:10.1177/10600280211038504]

  • Butragueno-Laiseca, L; Martin, GM; Cortes, RG; Galan, CR; de Marigorta, ZMDM; Anton, JG; Nunez, AR; Fernandez-Llamazares, CM; Manrique-Rodriguez, S; Cid, JLH.

    Multicenter randomized clinical trial comparing dexamethasone versus placebo in preventing upper airway obstruction after extubation in critically ill children

    Scientific Reports. 2022; 12(1): Nº de citas: 6 [doi:10.1038/s41598-022-08178-0]

  • Romero-Jimenez, R; Escudero-Vilaplana, V; Chamorro-de-Vega, E; Ais-Larisgoitia, A; Matilla, MEL; Herranz-Alonso, A; Sanjurjo, M.

    The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search

    JOURNAL OF MEDICAL INTERNET RESEARCH. 2022; 24(3): Nº de citas: 4 [doi:10.2196/31016]

  • Tejerina, F; Catalan, P; Rodriguez-Grande, C; Adan, J; Rodriguez-Gonzalez, C; Munoz, P; Aldamiz, T; Diez, C; Perez, L; Fanciulli, C; de Viedma, DG; Gregorio Maranon Microbiol ID COVI.

    Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19

    BMC INFECTIOUS DISEASES. 2022; 22(1): Nº de citas: 82 [doi:10.1186/s12879-022-07153-4]

  • García-Moreno FJ; Escobar-Castellanos M; Marañón R; Rivas-García A; Manrique-Rodríguez S; Mora-Capín A; Fernández-Llamazares CM.

    Adecuacy of pediatric antimicrobial prescribing in the Emergency Department at discharge.

    Anales De Pediatria. 2022; 96(3): 179-189 [doi:10.1016/j.anpede.2020.11.015]

  • Garcia-Moreno, FJ; Escobar-Castellanos, M; Maranon, R; Rivas-Garcia, A; Manrique-Rodriguez, S; Mora-Capin, A; Fernandez-Llamazares, CM.

    Adecuacy of pediatric antimicrobial prescribing in the Emergency Department at discharge

    ANALES DE PEDIATRIA. 2022; 96(3): 179-189 Nº de citas: 5 [doi:10.1016/j.anpedi.2020.11.019]

  • Garcia-Alfonso, P; Saiz-Rodriguez, M; Mondejar, R; Salazar, J; Paez, D; Borobia, AM; Safont, MJ; Garcia-Garcia, I; Colomer, R; Garcia-Gonzalez, X; Herrero, MJ; Lopez-Fernandez, LA; Abad-Santos, F.

    Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines

    CLINICAL & TRANSLATIONAL ONCOLOGY. 2022; 24(3): 483-494 Nº de citas: 31 [doi:10.1007/s12094-021-02708-4]

  • Villanueva-Bueno C; Montecatine-Alonso E; Jiménez-Parrilla F; Fernández-Llamazares CM; Manrique-Rodríguez S; Zamora-Flores E; Dolz E; Fernández-Polo A; Catillo-Salinas F; Comuñas J; Gallego-Fernández C; González-López M; Gómez-Trevecedo Calvo MT; Gázquez-Pérez R; Álvarez Del Vayo-Benito C; Gil-Navarro MV.

    Antimicrobial defined daily dose in neonatal population.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2022; 40(2): 59-65 [doi:10.1016/j.eimce.2021.05.012]

  • Narrillos-Moraza, A; Gomez-Martinez-Sagrera, P; Amor-Garcia, MA; Escudero-Vilaplana, V; Collado-Borrell, R; Villanueva-Bueno, C; Gomez-Centurion, I; Herranz-Alonso, A; Sanjurjo-Saez, M.

    Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale

    JMIR mHealth and uHealth. 2022; 10(2): Nº de citas: 7 [doi:10.2196/32826]